Novo Nordisk
NVO
NVO
901 hedge funds and large institutions have $15.2B invested in Novo Nordisk in 2022 Q1 according to their latest regulatory filings, with 84 funds opening new positions, 299 increasing their positions, 304 reducing their positions, and 60 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0.69% more ownership
Funds ownership: 14.87% → 15.56% (+0.69%)
0% more funds holding in top 10
Funds holding in top 10: 23 → 23 (0)
2% less repeat investments, than reductions
Existing positions increased: 299 | Existing positions reduced: 304
Holders
901
Holding in Top 10
23
Calls
$186M
Puts
$141M
Top Buyers
| 1 | +$499M | |
| 2 | +$161M | |
| 3 | +$60M | |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$56.1M |
| 5 |
VIP
Vantage Investment Partners
Kansas City,
Missouri
|
+$50.2M |
Top Sellers
| 1 | -$405M | |
| 2 | -$142M | |
| 3 | -$75.2M | |
| 4 |
Capital International Investors
Los Angeles,
California
|
-$33.6M |
| 5 |
Two Sigma Advisers
New York
|
-$29.8M |